Therapeutic antagonists and conformational regulation of integrin function

被引:288
作者
Shimaoka, M [1 ]
Springer, TA [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Anesthesia & Pathol, Boston, MA 02115 USA
关键词
D O I
10.1038/nrd1174
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Integrins are a structurally elaborate family of adhesion molecules that transmit signals bi-directionally across the plasma membrane by undergoing large-scale structural rearrangements. By regulating cell-cell and cell-matrix contacts, integrins participate in a wide range of biological processes, including development, tissue repair, angiogenesis, inflammation and haemostasis. From a therapeutic standpoint, integrins are probably the most important class of cell-adhesion receptors. Recent progress in the development of integrin antagonists has resulted in their clinical application and has shed new light on integrin biology. On the basis of their mechanism of action, small-molecule integrin antagonists fall into three different classes. Each of these classes affect the equilibria that relate integrin conformational states, but in different ways.
引用
收藏
页码:703 / 716
页数:14
相关论文
共 112 条
[1]   Does the integrin αA domain act as a ligand for its βA domain? [J].
Alonso, JL ;
Essafi, M ;
Xiong, JP ;
Stehle, T ;
Arnaout, MA .
CURRENT BIOLOGY, 2002, 12 (10) :R340-R342
[2]   Type II' to type I beta-turn swap changes specificity for integrins [J].
Bach, AC ;
Espina, JR ;
Jackson, SA ;
Stouten, PFW ;
Duke, JL ;
Mousa, SA ;
DeGrado, WF .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (01) :293-294
[3]   Are changes in integrin affinity and conformation overemphasized? [J].
Bazzoni, G ;
Hemler, ME .
TRENDS IN BIOCHEMICAL SCIENCES, 1998, 23 (01) :30-34
[4]   MONOCLONAL-ANTIBODY 9EG7 DEFINES A NOVEL BETA(1) INTEGRIN EPITOPE INDUCED BY SOLUBLE LIGAND AND MANGANESE, BUT INHIBITED BY CALCIUM [J].
BAZZONI, G ;
SHIH, DT ;
BUCK, CA ;
HEMLER, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) :25570-25577
[5]  
Bednar B, 1997, CYTOMETRY, V28, P58, DOI 10.1002/(SICI)1097-0320(19970501)28:1<58::AID-CYTO7>3.0.CO
[6]  
2-D
[7]  
Bednar RA, 1998, J PHARMACOL EXP THER, V285, P1317
[8]   Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation [J].
Beglova, N ;
Blacklow, SC ;
Takagi, J ;
Springer, TA .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (04) :282-287
[9]   Novel platelet inhibitors [J].
Bennett, JS .
ANNUAL REVIEW OF MEDICINE, 2001, 52 :161-184
[10]   Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated [J].
Billheimer, JT ;
Dicker, IB ;
Wynn, R ;
Bradley, JD ;
Cromley, DA ;
Godonis, HE ;
Grimminger, LC ;
He, BK ;
Kieras, CJ ;
Pedicord, DL ;
Spitz, SM ;
Thomas, BE ;
Zolotarjova, NI ;
Gorko, MA ;
Hollis, GF ;
Daly, RN ;
Stern, AM ;
Seiffert, D .
BLOOD, 2002, 99 (10) :3540-3546